Article Sidebar

pdf
Date Published: 25/06/2025
Abstract Views: 206
Views pdf: 77
DOI: https://doi.org/10.51298/vmj.v551i2.14666
Issue
Vol. 551 No. 2 (2025)
Section
Các bài báo
How to Cite
Nguyễn Văn, A., & Nguyễn Thị, T. (2025). DISTRIBUTION AND ANTIMICROBIAL RESISTANCE CHARACTERISTICS OF STREPTOCOCCUS SUIS CAUSING DISEASES ISOLATED AT MILITARY HOSPITAL 103 FROM 2014 TO 2021. Vietnam Medical Journal, 551(2). https://doi.org/10.51298/vmj.v551i2.14666

DISTRIBUTION AND ANTIMICROBIAL RESISTANCE CHARACTERISTICS OF STREPTOCOCCUS SUIS CAUSING DISEASES ISOLATED AT MILITARY HOSPITAL 103 FROM 2014 TO 2021

An Nguyễn Văn, Thu Nguyễn Thị

Main Article Content

Abstract

Objectives: To analyze the distribution and antimicrobial resistance characteristics of Streptococcus suis causing diseases at Military Hospital 103 from 2014 to 2021. Methods: This was a cross-sectional descriptive study on S. suis strains isolated from patients at Military Hospital 103 during the years 2014 to 2021. Results: The total number of S. suis strains isolated between 2014 and 2021 was 90. S. suis was mostly isolated from male (81.1%), blood (58.9%), and the Infectious Diseases Department (91.1%). S. suis strains showed the highest sensitivity to linezolid (98.41%), levofloxacin (97.10%), vancomycin (96.83%), and cefotaxim (91.94%). By contrast, the bacteria exhibited the lowest sensitivity to tetracyclin (8.06%) and clindamycin (16.95%). S. suis was the most resistant to tetracyclin (88.71%) and erythromycin (78.13%), and the least resistant to levofloxacin (1,45%), vancomycin (3,17%), and cefotaxim (3,23%). Conclusions: S. suis is mostly isolated from bloodstream infection patients. The bacterial strains showed the highest sensitivity to linezolid, levofloxacin, vancomycin, and cefotaxime, and the highest resistance to tetracyclin and erythromycin.

Article Details

Keywords

Streptococcus suis, bloodstream infection, antimicrobial resistance

References

1. Hughes, J.M., et al. (2009.), "Streptococcus suis: An Emerging Human Pathogen". Clinical Infectious Diseases, 48(5): p. 617-625.
2. Huong, V.T.L., et al. (2019.), "Burden of disease and economic impact of human Streptococcus suis infection in Viet Nam". Trans R Soc Trop Med Hyg, 113(6): p. 341-350.
3. Nguyen Thi Thao Nguyen, et al. (2021.), "An epidemiological study of Streptococcus suis prevalence among swine at industrial swine farms in Northern Vietnam". One Health, 13: p. 100254.
4. Clinical Lab Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing (M100). 31 ed. 2021: Clinical Lab Standards Institute.
5. Yu, H., et al. (2006.), "Human Streptococcus suis outbreak, Sichuan, China". Emerg Infect Dis, 12(6): p. 914-20.
6. Vu Thi Lan Huong, Ngo Thi Hoa, and P. Horby (2014.), "Raw pig blood consumption and potential risk for Streptococcus suis infection, Vietnam". Emerg Infect Dis, 20(11): p. 1895-8.
7. Thân Mạnh Hùng, Vũ Đình Phú, and Lê Văn Nam (2023.), "TÌNH TRẠNG KHÁNG KHÁNG SINH VÀ MỘT SỐ GEN KHÁNG THUỐC CỦA STREPTOCOCCUS SUIS GÂY BỆNH TRÊN NGƯỜI". Tạp chí Y học Việt Nam, 528(1).
8. Kerdsin, A. (2022.), "Human Streptococcus suis Infections in Thailand: Epidemiology, Clinical Features, Genotypes, and Susceptibility". 7(11): p. 359.